A kit to facilitate and standardize the processing of sputum for measurements of airway inflammation

Canadian Respiratory Journal

Volumn 20, Issue 4, 2013, Pages 248-252

  Chaboillez, Simone ^a   Dasgupta, Angira ^b   Prince, Philippe ^c   Boulet, Louis Philippe ^c   Lemière, Catherine ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b BR Singh Hospital   (India)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Method standardization; Sputum cell counts; Sputum processing

Indexed keywords

ARTICLE; CELL COUNT; CONTROLLED STUDY; EOSINOPHIL; HUMAN; HUMAN CELL; INFORMATION PROCESSING DEVICE; INTERMETHOD COMPARISON; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SPUTUM; VALIDITY;

EID: 84876223401     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2013/591316     Document Type: Article

References (18)

1. Nair PK, Hargreave FE. Airway diseases, inflammometry and individualized therapy. In: Polosa R, Holgate ST, eds. Therapeutic Strategies in Asthma: Current Treatments. Oxford: Clinical Publishing, 2007:155-64.
2. Nair P, Hargreave FE. Measuring bronchitis in airway diseases: Clinical implementation and applications. Chest 2010;138(2 Suppl):38S-43S.
3. Siddiqui S, Brightling CE, Airway disease: Phenotyping heterogeneity using measures of airway inflammation. J Allergy Asthm Clin Immunol 2007;3:60-9.
4. Lemiere C, Pizzichini MM, Balissoon R, et al. Diagnosing occupational asthma: Use of induced sputum. Eur Resp J 1999;13:482-8.
5. Girard F, Chaboillez S, Cartier A, et al. An effective strategy for diagnosing occupational asthma: Use of induced sputum. Am J Respir Crit Care Med 2004;170:845-50.
6. Lemiere C, D'Alpaos V, Chaboillez S, et al. Investigation of occupational asthma: Induced sputum or exhaled NO? Chest 2010;137:617-22
7. Jayaram L, Pizzichini MM, Cook RJ, et al. Determining asthma treatment by monitoring sputum cell counts: Effect on exacerbations. Eur Resp J 2006;27:483-94.
8. Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009;360:985-93.
9. Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360:973-84.
10. Lougheed MD, Lemiere C, Ducharme FM, et al; Canadian Thoracic Society Asthma Clinical Assembly. Canadian Thoracic Society 2012 guideline update: Diagnosis and management of asthma in preschoolers, children and adults. Can Respir J 2012;19:127-64.
11. Pizzichini MM, Popov T, Efthimiadis A, et al. Spontaneous and induced sputum to measure indices of airway inflammation. Am J Respir Crit Care Med 1996;154:866-9.
12. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
13. Gibson PG, Girgis-Gabardo A, Morris MM, et al. Cellular characteristics of sputum from patients with asthma and chronic bronchitis. Thorax 1989;44:693-9.
14. Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992;47:25-9.
15. Popov T, Gottschalk R, Kolendowicz R, Dolovich J, Powers P, Hargreave FE. The evaluation of a cell dispersion method of sputum examination. Clin Exp Allergy 1994;24:778-83.
16. D'silva L, Gafni A, Thabane L, et al. Cost analysis of monitoring asthma treatment using sputum cell counts. Can Respir J 2008;15:370-4.
17. Scheicher ME, Terra Filho J, Vianna EO. Sputum induction: Review of literature and proposal for a protocol. Sao Paulo Med J 2003;121:213-9.
18. Pizzichini E, Pizzichini MM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: Reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996;154(2 Pt 1):308-17.